Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Safety Follow-up After Growth Hormone Treatment (rhGH) of Short Children Born Small for Gestational Age (SGA)

NCT01491854 is registered in ClinicalTrials.gov with Sandoz as lead sponsor.

NCT NCT01491854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01491854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Safety Follow-up After Growth Hormone Treatment (rhGH) of Short Children Born Small for Gestational Age (SGA)
Lead sponsor
Sandoz
Phase
Not applicable
Overall status
Terminated
Start date
July 20, 2009
Completion date
October 31, 2018
Enrollment
130 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

short children born small for gestational age (sga)